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INTRODUCTION  
Cancer is the leading cause of death worldwide, accounting for 8.8 
million deaths in 2015 alone. Globally, nearly 1 in 6 deaths is due to cancer. 
Approximately 70% of cancer deaths occur in low- and middle-income  
countries. (1)  
The number of new cancer cases is expected to rise by about 70% over 
the next 2 decades with more than 60% of world‟s total new annual cases 
occurring in Africa, Asia and Central and South America. These regions also 
account for 70% of the world‟s cancer deaths.  
The most common causes for death worldwide are cancers of Lung (1.69 
million deaths), Liver (788000 deaths), Colorectal (774000 deaths),  
Stomach (754000 deaths), Breast (571000 deaths). (1)  
Carcinogenesis:  
Cancers arise from the transformation of normal cells into tumour cells in a 
multistage process that encompasses the stepwise accumulation of multiple 
mutations that act in a complementary way. These changes are the result of the 
interaction between a person's genetic factors and 3 categories of external agents 
including:  
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• Physical carcinogens, like exposure to ionizing radiation and ultraviolet 
rays;  
• Chemical carcinogens, like components of tobacco smoke, aflatoxin, 
asbestos and arsenic.  
• Biological carcinogens, like infections from certain viruses, bacteria, or 
parasites.  
Ageing is another fundamental factor for the development of cancer. The 
incidence of cancer rises dramatically with age, most likely due to a build-up of 
risks for specific cancers that increase with age. The overall risk accumulation 
is combined with less effective cellular repair mechanisms as a person grows 
older.   
Between 30–50% of cancers can currently be prevented. This can be 
accomplished by avoiding risk factors and implementing the existing evidence-
based prevention strategies. These risk factors include:  
• Being overweight or obese.  
• Unhealthy diet with low fruit and low vegetable intake.  
• Lack of physical activity.  
• Tobacco use, including cigarettes and smokeless tobacco.  
 11  
  
• Alcohol abuse.  
• Sexually transmitted HPV-infection.  
• Infection by hepatitis or other carcinogenic infections.  
• Ultraviolet and other ionizing radiation.  
• Urban air pollution.  
• Indoor smoke from household use of solid fuels.  
Tobacco use is the single most important risk factor for cancer and is 
responsible for approximately 22% of cancer-related deaths globally. (1) The 
cancer burden can also be reduced through early detection of cancer and 
management of patients who develop cancer. Many cancers have a high 
chance of cure, if diagnosed early and treated adequately. Early diagnosis 
consists of 3 steps that must be integrated and provided in a timely manner.  
1. Awareness and accessing care.  
2. Clinical evaluation, diagnosis and staging.  
3. Access to treatment.(1)  
First reports of Fine needle aspiration cytology (FNAC) as a technique 
to obtain diagnostic material date back to the 19th century. FNAC was initially 
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a means to confirm a clinical suspicion of local recurrence or metastasis of 
known cancer without subjecting the patient to further surgical intervention. 
Following success in this area, the interest focused on preliminary preoperative 
diagnosis of all kinds of neoplastic processes, benign or malignant, in any organ 
or tissue of the body and on definitive, specific  
diagnosis in inoperable cases as a guide to rational treatment. (63)  
Fine Needle Aspiration Cytology (FNAC) when used alongside clinical 
and radiological assessment offers a relatively cheap, quick, and accurate tool 
for the diagnosis of cancer.(2) Due to its low cost, it is also being used for the 
differential diagnosis between benign and malignant lesions in the primary care 
units of many under developed countries.(9)  
For many years, efforts have been made to develop methods to enhance 
the sensitivity and specificity of cytological smears. From this research and 
development, Liquid Based Preparation of cytological samples has evolved. 
Liquid-based cytology (LBC) is a technique that enables cells to be suspended 
in a monolayer, through which better morphological assessment is possible. It 
includes the preparation and evaluation of cells collected in a liquid fixative, the 
cells are then transferred in a representative manner and operator dependent 
variation will not occur. Though initially advised for gynaecology samples, it is 
increasingly being used for non-gynaecologic cytology samples and FNA 
samples also. (3, 4) Two technologies - Thin Prep (Cytyc Corp.) and SurePap 
(Tripath imaging, Inc.) have been more widely used and are FDA approved.(6)  
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Compared with conventional preparation, Liquid based Preparation has 
a number of advantages with regard to nuclear and cytoplasmic morphology, 
cell size and background material. Liquid based Preparation also allows for 
rapid fixation, decreased obscuring factors and standardisation of cell transfer. 
The advantages of liquid-based cytology include improved sensitivity and 
specificity, since fixation is better and nuclear details are well preserved. 
Abnormal cells are not obscured or diluted by other epithelial or inflammatory  
cells. There is, therefore, a lower rate of unsatisfactory cytology samples. (4, 8) 
The residual cell suspension can also be used to make further cytological 
preparations. More over immunocytochemistry can also be performed on the  
residual sample. (5)  
Owing to the high cost of setup, manual methods of liquid based 
cytology are under evaluation. UPREP liquid based cytology system is a new 
and advanced system in the Manual Liquid based Preparation. The principle 
behind UPREP Liquid based Cytology procedure is surface adsorption by  
RCF (6).  
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 AIMS AND OBJECTIVES:  
To compare FNAC smears made by conventional preparation and  
UPREP liquid based preparation.  
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REVIEW OF LITERATURE  
HISTORICAL ASPECTS:  
Since the 15th century, syringes or equivalent instruments have been used 
to aspirate collections of fluids. With the introduction of achromatic 
microscopes and their industrial production in the 1830s, the microscope 
became cheaper and hence accessible to many observers who used it to examine 
the aspirated material. It has been mentioned that a French physician, Kün, and 
a German-Swiss pathologist, Lebert, described in 1847 and 1851, the use of a 
cannula to secure cell samples from palpable tumours and used the microscope 
to identify cancer. Sporadic use of aspirated samples has been described in the 
literature of the second half of the 19th century and in the first years of the 20th 
century. An important contribution was published in 1905 by two British 
military surgeons, Greig and Gray, working in Uganda who aspirated the 
swollen lymph nodes, by means of a needle and a syringe, in patients with 
sleeping sickness to identify the motile trypanosome.   
By the beginning of the 20th century, the first aspiration biopsy aiding 
in diagnosis of a solid tumor was published by Hirschfeld (1912), who also 
became the first person to use a small-calibre needle. The most notable 
development in diagnostic aspiration biopsy was a paradoxical event. James 
Ewing, the Director of the Memorial Hospital for Cancer in New York City and  
Professor of Pathology at Cornell University Medical School, who was also a 
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dominant figure in American oncologic pathology between 1910 and 1940. 
Although Dr. Ewing has made great contributions to the classification and 
identification of human cancer, he adamantly opposed to tissue biopsies because 
he believe that it allegedly contributed to the spread of cancer. Due to the ban 
on tissue biopsies, Hayes Martin a young surgeon and radiotherapist at the 
Memorial Hospital, began to aspirate palpable tumours of various organs by 
means of a large-calibre needle and a Record syringe. His colleague Edward 
Ellis prepared the material in the form of air-dried smears and stained with 
haematoxylin and eosin. Tissue fragments (named clots) were further embedded 
in paraffin and processed as cell blocks. Palpable lesions of lymph nodes, breast, 
and thyroid were the initial targets of aspiration. The material was interpreted 
by Ewing's associate and subsequent successor Dr. Fred W. Stewart.   
This method proved to be very successful and accurate with very few 
errors and clinical complications. Martin and Ellis published their conjoined 
initial results in 1930 and 1934. In 1933, Dr. Fred W. Stewart published a classic 
article, “The Diagnosis of Tumours by Aspiration,” in which he discussed, at 
length, the pros and cons of this method of diagnosis, its achievements, and 
pitfalls, based on experience with 2500 samples. This method of aspiration 
pioneered by Martin has remained a standard diagnostic procedure at Memorial 
Sloan-Kettering Cancer Center, the only institution in the world where the 
procedure has remained in constant use for more than 75 years.   
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In the 1940s, Paul Lopes-Cardozo and Nils Söderström, experimented 
on a large scale with this system of diagnosis, using small-calibre needles and 
hematologic techniques to process the smears.   
By the 1970s, special aspiration biopsy clinics were established in 
Stockholm and Sweden to which patients with palpable lesions were provided 
referral to higher centres, for diagnosis. The technique became an acceptable 
substitute for tissue biopsies.   
Broad acceptance of exfoliative cytology techniques (Pap smears) for 
detection and diagnosis of cervix cancer, played a major role in the development 
and acceptance of Fine needle aspiration.  
After timid beginnings in the early 1970s, a new era of diagnosis began, 
pathologists started accepting the cytologic sample as clinically valid and 
important. By late 1900‟s biopsy by aspiration, also known as thin- or fine-
needle aspiration biopsy (FNA), had become an important diagnostic technique, 
sometimes replacing but often complementing tissue pathology in many clinical 
situations.  
In 1987 an article in the Wall Street Journal by an investigative 
journalist, Walt Bogdanich, on the failure of laboratories to identify cancer of 
the cervix in young women, elicited a great deal of attention. This prompted the 
Congress of the United States in 1988 to promulgate a law, known as the 
Amendment to the Clinical Laboratory Improvement Act (CLIA 88),  
 18  
  
governing the practice of gynecologic cytology in the United States. Suffice it 
to say, cytopathology, particularly cervicovaginal smears, became the object of 
intense scrutiny and legal proceedings against pathologists and laboratories for 
alleged failure to interpret the smears correctly, casting a deep shadow on this 
otherwise very successful laboratory test.  
As a consequence of these events, several manufacturers brought about 
changes in collection and processing of the cervicovaginal smears. The 
collection methods of cervical material in liquid media, followed by automated 
processing with resulting “monolayer” preparations, have been approved by the 
Food and Drug Administration (USA) in 1996. (7, 63)  
Diagnostic cytology:  
It is based on four basic sampling techniques:  
1. Collection of exfoliated cells.  
2. Collection of cells removed by brushing or similar abrasive techniques.  
3. Aspiration biopsy (FNA) or removal of cells from palpable or deeply 
seated lesions by means of a needle, with or without a syringe.   
4. Intraoperative cytology.  
Fine Needle Aspiration Cytology – Techniques and Smear Preparation:  
Needles:  
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Hypodermic, disposable needles with long bevels are well suited for 
aspiration. The needles may vary in size from 22 to 27 gauge. The choice of 
gauge depends upon extend to access and quantity to drain according to each 
case. Larger-bore needles are needed for the evacuation of extremely viscous 
fluid, so as to collect more material from loosely structured cellular organs 
(liver) or lesions (melanomas, small cell tumours, and lymphomas). On the 
other hand, the smaller-bore needles are more effective for sampling tissue with 
few epithelial cells and extensive fibrosis as they penetrate the stroma more 
easily and also are more effective in securing the epithelial cell component for 
example in an invasive lobular carcinoma and fibrocystic change with the 
dominant fibrous component in the breast.   
Syringes and Syringe Holders:  
Slip Tip disposable syringes with an eccentric tip are recommended 
because of the ease of removing and reattaching the needle. A syringe holder 
can be used when a free hand is needed to stabilize the palpable target during 
sampling. The syringe holder should hold the syringe firmly, be comfortable to 
hold, easy to clean, and should not slip easily out of position. It should also 
allow easy removal of the needle and retraction of the plunger without the need 
of removing the syringe from the holder. A syringe holder that fits a 10ml rather 
than a 20-ml syringe is easier to handle as the shorter 10-ml syringe decreases 
the distance between the hand and the target, making sampling  
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easier.   
A pencil-grip syringe holder developed by Tao and Smith, named The 
Tao Aspirator is easy to handle and offers a pre-setting of negative pressure to 
achieve adequate suction.  
A supply of clean microscopic slides, coverslips, ingredients, fixatives, 
alcohol scrubs, for rapid stains, sterile gauze, and band aids must be available 
before the procedure is initiated. Slides with frosted ends are preferable for 
proper labelling with pencil for easy identification of the patients.  
Patient Selection:  
One of the great advantages of FNAC is that it can be applied to almost 
any patient regardless of physical status, except in deep-seated targets and in 
patients with clotting disorders. The procedure causes very few, mostly 
insignificant side effects and only slight discomforts.  
Contraindications:  
Sampling of carotid body tumours and pheochromocytomas may cause 
syncope and episodes of acute hypertension. Serious complications in the 
aspiration of hydatid cysts, include anaphylactic shock. Haemorrhagic 
diathesis, extremely vascular lesions, and the patient's inability to cooperate 
may be considered contraindications to deep-seated FNA. Likewise, severe 
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emphysema, pulmonary hypertension, and conditions associated with severe 
hypoxemia are also contraindications to FNA sampling of chest lesions.  
Patient Preparation:  
Procedure should be carefully explained with a discussion of possible 
side effects. Informed consent must be obtained. For superficial lesions, local 
anaesthesia is optional. Local anaesthesia is routinely employed when sampling 
deep-seated targets with the aid of CT or ultrasonic guidance, as these 
procedures last longer and may be more painful. Moreover several attempts may 
be needed to position the needle correctly, and the needle tip must often pass 
through muscle, which is especially sensitive to needle sticks.  
A simple disinfection protocol of wiping the skin at and around the biopsy site 
with an alcohol-soaked swab is sufficient for superficial lesions. For deepseated 
lesions, it is common practice to cleanse a larger area of skin and use sterile 
gloves and draping. This facilitates the insertion of the highly flexible needle 
by allowing the operator to hold onto and stabilize the shaft during insertion.  
BASIC ASPIRATION TECHNIQUE:   
Palpation of the Target and Planning of the Procedure:  
First the lesion should be carefully palpated, and its size and distance 
from the overlying skin should be assessed. In small lesions (l cm in diameter), 
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it is desirable to aim for the centre of the lesion. In medium-sized lesions (2 to 
4 cm in diameter), it is advantageous to collect samples from two different areas, 
one to the side of the centre, and another one in the mirrorimage position of the 
previous aspiration. This approach will yield a more representative harvest. 
Also, the second sample is extracted from an area not previously disturbed by 
the needle, thereby decreasing the likelihood of contamination with excessive 
amounts of blood. In case of very large lesions (>5 cm in diameter), there may 
be central necrosis, and thus the periphery is more likely to yield diagnostic 
material.  
Immobilization of the Target:   
Lesions over 3 cm in diameter can be held in place with the thumb and 
forefinger. Smaller lesions (1 to 2.5 cm) can be more effectively immobilized 
between the forefinger and middle finger. Stretching the overlying skin tightly 
across the lesion further helps immobilize the target. Without moving the 
fingers, cleanse the skin with an alcohol swab or other disinfectant prior to 
aspiration.  
Insertion of the needle:  
Once the target has been secured, the previously assembled aspiration 
instrument must be picked up and the needle tip inserted into the target.  
Suction is applied by retracting the syringe plunger to the 1ml to 2ml mark. 
Pumping the plunger up and down during the procedure should be avoided, as 
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it detracts from essential needle movement and does not add to the quantity or 
quality of the sample.  
Aspiration procedure:  
Once suction has been applied, the needle tip must be moved back and 
forth within the target. To collect sufficient material for at least two smears, 
typically 15 to 20 needle movements are required. Major changes in the 
direction of the needle must be avoided because they may cause bleeding, unless 
the procedure outlined below is carefully followed. Using this approach, 
optimal amounts of tissue will be collected in a short time with minimal 
bleeding and discomfort. At least one additional aspiration should be performed 
routinely to ensure representative sampling. However, if the first sample shows 
unequivocal evidence of a malignant, no further sampling is necessary unless 
material for special studies is required.  
Withdrawal of the needle:   
After collecting the sample, release the suction before withdrawing the 
needle. This allows the collected material to stay within the needle and syringe 
tip. If suction is maintained while the needle is withdrawn, the collected 
material will be sucked into the barrel of the syringe and will be difficult to 
expel. After the needle is withdrawn from the lesion, remove the needle from 
the syringe and pull back on the plunger. Then reattach the needle and expel the 
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material onto a glass slide by pushing the plunger swiftly through the syringe. 
In order to avoid splattering, the tip of the needle should rest on the slide.  
ASPIRATION WITHOUT A SYRINGE:  
Zajdela et al described a sampling technique that uses a thin needle 
without suction. The target is identified and immobilized. Then the needle, held 
by the hub is placed within the target and is moved back and forth to collect 
small fragments of tissues. The fragments are collected within the shaft of the 
needle. The hub-opening of the needle should be left uncovered during 
sampling. The main advantage of this technique is the ease with which the 
needle can be accurately positioned in the target. The thin needle is also easier 
to manipulate when it is not attached to a syringe. This simple technique also 
often enhances the differences in consistency between lesion and the 
surrounding normal tissue. In addition, sampling without suction may reduce 
the amount of blood when highly vascular lesions or organs are sampled. 
Typically, the volume of the harvested material is usually smaller than that 
obtained by procedures that apply suction. However, the smaller volume may 
be more representative of the lesion. Sampling without suction may be 
especially useful in small, highly vascularised targets, such as the thyroid, and 
in other sites with abundant blood supply. This technique is not recommended 
for aspirating cystic lesions containing fluid. (80)  
SIDE EFFECTS AND COMPLICATIONS:  
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The most common complication is local hematoma in and around the 
mass. The bleeding may occur during the sampling or for a few minutes after 
withdrawal of the needle. The size of the hematoma can be minimized by 
applying firm pressure to the mass and the surrounding area immediately 
following the sampling. If the patient has a bleeding disorder or is on type of 
medications that interferes with blood clotting, the post-aspiration pressure 
should be extended for up to 10 minutes.  
Local infection is extremely rare, and can be managed with antibiotics.  
No serious infections following FNA of superficial targets have been reported. 
Deep-Seated Targets  
The complication rates for deep-seated targets are higher than those for 
superficial targets, and occasional fatalities have been reported. Serious 
bleeding will occur if the needle tip lacerates the liver or splenic capsule. The 
risk of laceration is significantly increased if the patient is not able to cooperate 
with breathing instructions. To minimize the risk of serious haemorrhage, the 
patient's coagulation parameters should be evaluated before the procedure. It is 
advisable to temporarily stop medication that interferes with coagulation to 
reduce the risk of haemorrhage.  
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BASIC SMEAR PREPARATION TECHNIQUES:  
The basic one-step smearing technique is to process a harvest consisting 
of one or two droplets of semisolid tissue material. The nondominant hand 
steadies the needle as the needle tip, bevel down, and is touched to the frosted 
(proximal) end of a clean slide. The harvest (or part of it) is expelled onto the 
slide in the form of a droplet. The slide is picked up by its frosted end between 
the thumb and forefinger of the non-dominant hand. The other fingers are used 
to create a steady platform beneath the slide. A clean slide is then held by its 
frosted end in the dominant hand. Its lower long edge is placed against the first 
slide at a 45° to 90° angle proximal to the droplet. This top edge of the slide is 
then lowered until it touches and then covers the droplet and the two slides are 
flush. At this point, the material is spread in one smooth motion by pulling the 
top slide along the entire length of the bottom slide. The movement should be 
smooth and fairly rapid and not hurried. It is very important to keep the two 
slides parallel to each other during smear preparation to avoid scraping the 
bottom slide. As soon as the smear has been prepared, the first (bottom) slide 
should be fixed. Any delay in fixation will result in air-drying artefacts. The 
second (top) slide used for smear preparation usually contains no diagnostic 
material and can be reused to make several smears from the same harvest.  
When the droplet is large, the material can be divided to prepare 
additional smears. For this, two slides are initially positioned as for the onestep 
smear technique. The top slide is then gently rotated down until it just touches 
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the droplet, thus picking up a portion of this material. The two slides are then 
separated. The top slide is kept in the dominant hand and is used to prepare a 
smear via the one-step method, using a new clean slide as the bottom slide. 
Finally, a smear is made of the original droplet, again using the one-step 
technique.  
 
 
FIXATION AND STAINING OF ASPIRATED MATERIAL:  
The most commonly used stains for smears of aspirated material are the 
Papanicolaou, hematoxylin-eosin, and Romanowsky-type stains.  
The Papanicolaou stain requires immediate fixation in alcohol before the 
smears start to dry. Ethanol (95%) is most commonly used; methanol in a 70% 
to 95% solution also produces good results.   
Smears intended for Romanowsky-type stains are air-dried before the 
staining procedure is initiated, and can be stored indefinitely in their unstained 
state.   
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Rapid Staining Techniques:  
A rapid staining technique is valuable for a preliminary evaluation of 
material before the patient is released. The main purpose is to ascertain that 
adequate material has been collected. This approach facilitates the decision as 
to whether to collect additional material for special studies in selected cases. In 
addition, in many cases a preliminary diagnostic assessment can also be made. 
Examples: fast version of the Papanicolaou method, the hematoxylineosin stain 
designed for frozen sections, Diff-Quik or May-GrüenwaldGiemsa stains with 
the staining time reduced to 2 minutes for each, and toluidine blue, which is so 
far the fastest.  
Advantage of Fine needle aspiration cytology:   
(1) Rapidity of diagnosis.  
(2) High acceptance.  
(3) Cost-effectiveness.  
(4) High sensitivity and specificity. (74)  
(5) Ability to sample multiple areas at a single go.  
(6) Preoperative planning.  
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(7) Sampling of metastatic as well as the primary site.  
(8) Performance of ancillary techniques.  
(9) A rapid psychological relief to the patient following a negative  
diagnosis. (10)  
  
Limitations of Fine needle aspiration cytology:   
(1) Results and accuracy are highly dependent on the quality of samples  and 
smears.  
(2) Samples obtained with a fine needle may not be representative in case of 
a heterogeneous lesion or under USG guidance.  
(3) Lesions recognised mainly on the specific micro architectural pattern, 
which may not be sufficiently represented in cytological preparations.   
(4) Ancillary techniques like immune markers cannot be done.  
(5) Precise cytological criteria have not yet been defined in some rare 
conditions.  
Continuous frequent exposure to a particular category of tumours has 
been clearly shown to be a major factor deciding diagnostic accuracy. On the 
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other hand, because such cases will be seen initially in general medical practices 
and surgical clinics, all cytopathologists must be able to at least categorise the 
condition and suggest the appropriate referral. This requires a wide knowledge 
of the range of possible conditions in any given site.  
 
 
 
Thyroid Gland:  
Sampling of a mass in the thyroid gland is easiest if the patient lies flat 
on the back, either without a pillow or with a thin pillow under the head. 
However, if stretching the neck brings the mass forward and makes it easier to 
palpate, then this is the best position for the patient to be in.  
To make sure that the mass is in the thyroid, feel the mass move up and 
down on deglutition before sampling. Immobilizing a target in the thyroid gland 
is best achieved by pushing the lesion against the trachea, using the volar aspects 
of the forefinger and middle finger. The sternocleidomastoid muscle should be 
pushed to a lateral position and should not be allowed to cover the target. Also, 
small fragments of muscle may plug the needle, jeopardizing subsequent 
sampling of the target. Ideally, the angle of the needle should be tangential to 
the trachea. This way, the needle will be less likely to penetrate the trachea, with 
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resulting loss of the sample in the barrel of the syringe. The tangential approach 
also allows easier sampling of small and/or flat lesions close to the trachea. It is 
important for the patient to refrain from swallowing during the sampling.   
By early 2000‟s routine use of FNA for the preoperative diagnosis in 
thyroid nodules started being the norm. It also helped to reduce the rate of 
unnecessary thyroid surgery for patients with benign nodules and hence 
appropriately triage patients with thyroid cancer to appropriate surgery. Before 
the routine use of thyroid FNA, the percentage of surgically resected thyroid 
nodules that were malignant was 14%. (23) With current thyroid FNA practice, 
the percentage of resected nodules that are malignant, surpasses 50%.(24)  
Historically, terminology for thyroid FNA had varied significantly from 
one laboratory to another, thus creating confusion in cases and also hindering 
the sharing of clinically meaningful data among multiple institutions. With 
routine use of FNA in thyroid cases, it became critical that cytopathologists 
communicate thyroid FNA interpretations to referring physicians in terms that 
are succinct, unambiguous, and clinically helpful.  
To address the terminology and other issues related to thyroid FNA, the  
National Cancer Institute (NCI) hosted “NCI Thyroid Fine Needle Aspiration  
State of the Science Conference.” The meeting was organized Dr.  Andrea 
Abati, MD, and took place on October 22 and 23, 2007, in Bethesda, MD. 
Edmund S. Cibas, MD, and Susan J. Mandel, MD, MPH, served as  
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moderators. Zubair W. Baloch, MD, PhD, served as chair of the Terminology 
and Morphologic Criteria committee.   
The inspiration for thyroid proposal was the “Bethesda System for 
reporting cervical cytology” interpretations, first developed at an NCI workshop 
in 1988 and widely adopted for reporting cervical pap smears. It was expected 
that the many benefits, clinical and investigational, of the Bethesda cervical 
terminology would also apply to the Bethesda thyroid terminology.   
A uniform reporting system for thyroid FNA would facilitate effective 
communication among cytopathologists, endocrinologists, surgeons, 
radiologists, and other health care providers; thus facilitating 
cytologichistologic correlation for thyroid diseases. It would also facilitate 
research into epidemiology, molecular biology, pathology, and diagnosis of 
thyroid diseases, particularly in neoplasia and allow for the easy and reliable 
sharing of data from different laboratories for national and international 
collaborative studies.  
The Bethesda System for Reporting Thyroid Cytology (TBSRTC):  
Category I: Non diagnostic or Unsatisfactory:  
All thyroid FNA must be evaluated for adequacy. Inadequate samples 
are reported as “nondiagnostic” (ND) or “unsatisfactory” (UNS). This applies 
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to specimens that were unsatisfactory owing to obscuring blood, overly thick 
smears, air drying of alcohol-fixed smears, or due to inadequate number of  
follicular cells.   
Exceptions included are:   
• Any specimen that contained abundant colloid was considered  
adequate (and benign), even if 6 groups of follicular cells were not 
identified.   
• Whenever a specific diagnosis (eg, lymphocytic thyroiditis) can be 
rendered and whenever there is any atypia, the specimen is, by definition, 
adequate for evaluation.   
ND/ UNS results occurred in 2% to 20% of cases but ideally should be 
limited to no more than 10% of thyroid FNAs, excluding samples composed 
exclusively of macrophages. (27,28)  
At the 2007 NCI Conference, it was decided that cyst-fluid-only (CFO) 
cases should be considered a clearly identified subset of ND/UNS. The 
significance and clinical value of a CFO result depend in large part on 
sonographic correlation.   
In a study that segregated CFO cases and analyzed them separately, the 
risk of malignancy for a CFO sample was 4%.(28) The risk of malignancy for 
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ND/UNS (not including CFO) is 1% to 4%.(27,28,29) A repeated aspiration with 
ultrasound guidance is recommended for ND/UNS and clinically or 
sonographically worrisome CFO cases and is diagnostic in 50% to 88% of 
cases, but some nodules remain persistently ND/ UNS. Excision is considered 
for persistently ND/UNS nodules because about 10% prove to be malignant.(30) 
Unless specified as ND/UNS, the FNA specimen is considered adequate for 
evaluation.   
 
Category II:  Benign  
• Benign Follicular Nodule (BFN) : refers to an adequately cellular 
specimen composed of varying proportions of colloid and benign 
follicular cells arranged as macrofollicles and macrofollicle fragments. 
The false-negative rate of a benign interpretation is low (0%-3%),(24,31) 
but patients are nevertheless followed up with repeated assessment by 
palpation or ultrasound at 6- to 18-month intervals.(32) If the nodule 
showed significant growth or “suspicious” sonographic changes, a  
repeated FNA can be considered.   
• “Consistent with lymphocytic (Hashimoto) thyroiditis in the proper 
clinical context” and “Consistent with granulomatous (sub-acute) 
thyroiditis.” This is a partial list and does not include a variety of other 
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benign conditions like infections and amyloid goitre that are 
occasionally sampled by FNA. Additional benign findings (eg: black 
thyroid, reactive changes, radiation changes, cyst lining cells) can be 
mentioned as descriptive diagnoses at the discretion of the  
cytopathologist.  
• Category III: Atypia of Undetermined Significance or Follicular Lesion 
of Undetermined Significance   
Some thyroid FNAs are not easily classified into the benign, suspicious, 
or malignant categories. The heterogeneity of this category precludes 
outlining all scenarios for which an AUS interpretation is appropriate.   
• A prominent population of microfollicles in an aspirate that does not 
otherwise fulfill the criteria for “follicular neoplasm/suspicious for 
follicular neoplasm.” This situation may arise when a predominance of 
microfollicles is seen in a sparsely cellular aspirate with scant colloid. 
Alternatively, a more prominent than usual population of microfollicles 
may occur in a moderately or markedly cellular sample, but the overall 
proportion of microfollicles is not sufficient for a diagnosis of follicular 
neoplasm/suspicious for follicular neoplasm.   
• There is a predominance of Hürthle cells in a sparsely cellular aspirate 
with scant colloid.   
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• The interpretation of follicular cell atypia is hindered by sample 
preparation artefact, eg: 1) Air-drying artefact with slight nuclear and 
cytoplasmic enlargement, pale and slightly smudgy chromatin, and/or 
mildly irregular nuclear contours 2) Clotting artefact with crowding.   
A moderately or markedly cellular sample is composed of a virtually 
exclusive population of Hürthle cells, yet the clinical setting suggests a benign 
Hürthle cell nodule, eg: 1. Lymphocytic (Hashimoto) thyroiditis 2. Multi 
nodular goitre   
There are focal features suggestive of papillary carcinoma, including 
nuclear grooves, enlarged nuclei with pale chromatin, and alterations in nuclear 
contour and shape in an otherwise predominantly benign-appearing sample 
(especially in patients with Hashimoto thyroiditis or with abundant colloid and 
other benign-appearing follicular cells).   
There are cyst-lining cells that may appear atypical owing to the presence 
of nuclear grooves, prominent nucleoli, elongated nuclei and cytoplasm, and/or 
intranuclear cytoplasmic inclusions in an otherwise predominantly benign 
appearing sample.(33)  
A minor population of follicular cells show nuclear enlargement, often 
accompanied by prominent nucleoli.  
 Eg:  1.  Specimens from patients with a history of treatment with  
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radioactive iodine, carbimazole, or other pharmaceutical agents.  
 2.  Repair due to involutional changes such as cystic degeneration  
and/or hemorrhage.  
There is an atypical lymphoid infiltrate (in which a repeated aspirate for 
flow cytometry is desirable), but the degree of atypia is insufficient for the 
general category “suspicious for malignancy.”   
Not otherwise categorized: only nodules with atypia of undetermined 
significance should be placed in the AUS category. Recognizably benign 
cellular changes (eg, typical cyst lining cells, focal Hürthle cell change, changes 
ascribed to radioiodine therapy, black thyroid) should not be interpreted as 
AUS. A moderately or even highly cellular specimen by itself (without 
significant nuclear or architectural atypia) does not qualify a nodule for an AUS 
interpretation. An AUS result is obtained in 3% to 6% of thyroid FNAs. (25,30) 
Higher rates likely represent overuse of this category when other interpretations 
are more appropriate. The recommended management is clinical correlation and 
a repeated FNA at an appropriate interval. (25,33) In most cases,  repeated FNA 
can result in a more definitive interpretations, of which only about 20% of 
nodules are repeatedly AUS.(25) The risk of malignancy for an AUS nodule is 
difficult to ascertain because only a minority of cases in this category have 
surgical follow-up. Those that are resected represent a selected population of 
patients with repeated AUS results or patients with worrisome clinical or 
sonographic findings. In this selected population, 20% to 25% of patients with 
 38  
  
AUS prove to have cancer after surgery, but this is undoubtedly an overestimate 
of the risk for all AUS interpretations. (25, 30) The risk of malignancy is certainly 
lower and probably closer to 5% to 15%.   
Category IV : Follicular Neoplasm or Suspicious for a Follicular Neoplasm   
This diagnostic category helps to identify a nodule that might be a 
follicular carcinoma (FC) and triage it for surgical lobectomy. FCs have 
cytomorphologic features that distinguish them from benign follicular nodules. 
Although these cytomorphologic features do not permit distinction from a 
follicular adenoma (FA), they are reportable as “follicular neoplasm” (FN) or 
“suspicious for a follicular neoplasm” (SFN), leading to a definitive diagnostic 
procedure, usually lobectomy. About 15% to 30% of cases called  
FN/SFN prove to be malignant. The majority of FN/SFN cases turn out to be 
FAs or adenomatoid nodules of multinodular goiter, both of which are more 
common than FC. Of those that prove to be malignant, many are FCs, but a 
significant proportion are follicular variants of papillary carcinoma. Cytologic 
preparations typically have high cellularity, with scant or absent colloid. The 
hallmark of this diagnostic category is a disturbed cytoarchitecture: follicular 
cells which are arranged predominantly in microfollicular or trabecular pattern. 
Cases that demonstrate the nuclear features of papillary carcinoma are excluded 
from this category. Cellular crowding and overlapping are conspicuous, and the 
follicular cells are usually larger than normal. Nuclear atypia or pleomorphism 
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and mitoses are uncommon. A minor population of macrofollicles (intact 
spheres and fragments) can be present. Conspicuous cellularity alone does not 
qualify the nodule for a suspicious interpretation. If the sample is cellular but 
mostly macrofollicular, a benign interpretation is appropriate. Benign follicular 
nodules often have a small population of microfollicles and crowded groups. If 
these constitute the minority of the follicular cells, they have little significance 
and the FNA can be interpreted as benign. A suspicious interpretation is 
rendered only when the majority of the follicular cells are arranged in abnormal 
architectural groupings (microfollicles, crowded trabeculae). The general 
category FN/SFN is a selfsufficient interpretation; narrative comments that 
follow are optional. In the World Health Organization classification, Hürthle 
cell adenoma and Hürthle cell carcinoma are considered oncocytic variants of 
FA and FC, respectively. Studies suggest, however, that follicular and Hürthle 
cell tumors have different underlying genetics. For this reason, and because they 
have such distinctive morphologic features, it is helpful to specify that a sample 
raises the possibility of a Hürthle cell rather than a follicular neoplasm. This 
interpretation applies to cellular samples that are composed exclusively (or 
almost exclusively) of Hürthle cells. Oncocytic cells with nuclear features of 
papillary carcinoma are excluded from this interpretation. A significant 
proportion of these cases (16%-25%) prove not to be neoplasms but rather 
hyperplastic proliferations of Hürthle cells in nodular goiter or lymphocytic 
thyroiditis.  About 15% to 45% of nodules are malignant, and the remainder of 
the neoplasms prove to be Hürthle cell adenomas.  
 40  
  
  
  
Suspicious for Malignancy:   
Most cases of papillary thyroid carcinoma (PTC), can be diagnosed with 
certainty by FNA. However the nuclear and architectural changes of some PTCs 
are subtle and focal. This is particularly true of the follicular variant of PTC, 
which can be difficult to distinguish from a benign follicular nodule. Other 
PTCs may be incompletely sampled and yield only a small number of abnormal 
cells. If only 1 or 2 characteristic features of PTC are present, if they are only 
focal and not widespread throughout the follicular cell population, or if the 
sample is sparsely cellular, a malignant diagnosis cannot be made with 
certainty. Such cases occur with some regularity, and they are best classified as 
“suspicious for malignancy,” qualified as “suspicious for papillary carcinoma.” 
Nodules called suspicious for papillary carcinoma are resected by lobectomy or 
thyroidectomy. Most (60%-75%) prove to be papillary carcinomas, and the rest 
are usually FAs.  
The same general principle applies to other thyroid malignancies like 
medullary carcinoma and lymphoma, but these are encountered less frequently 
than PTC. Ancillary testing (eg, immunohistochemical analysis, flow 
cytometry) in borderline cases is usually more helpful with medullary 
carcinoma and lymphoma than with PTC.  
Malignant:   
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The general category malignant is used whenever the cytomorphologic 
features are conclusive for malignancy. Descriptive comments that follow are 
used to sub classify the malignancy and summarize the results of special studies, 
if any. Approximately 3% to 7% of thyroid FNAs have conclusive features of 
malignancy, and most are papillary carcinomas. Malignant nodules are usually 
removed by thyroidectomy, with some exceptions (eg: metastatic tumours, non-
Hodgkin lymphomas, and undifferentiated carcinomas). The positive predictive 
value of a malignant FNA interpretation is 97% to 99%.  
Rabia Basharat et al conducted a comparative study at the Department of 
Pathology at King Edward Medical University titled „Comparison of FNAC 
and thyroid scan in solitary thyroid nodule‟. This study comprised of 50 patients 
diagnosed clinically with solitary thyroid nodules (STN) and who underwent 
thyroid function tests and thyroid scan (TS). These patients later underwent 
FNAC in the department of Pathology, Mayo Hospital. The cases were operated 
and evaluated for histopathological changes. Thyroid scan revealed that 40 
patients (80%) having cold nodules were labeled as suspicious, 10 patients 
(20%) had hot nodule. On FNAC 23 patients (46%) had benign lesions, 22 
patients (44%) had indeterminate lesions and 5 patients  
(10%) had malignant lesions. On histopathologic examination, 45 patients 
(90%) were confirmed to have benign lesions and 5 patients (10%), malignant 
lesions. After comparison of results of thyroid scan and FNAC with  
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histopathology, the sensitivity, specificity, positive predictive value, negative 
predictive value and diagnostic accuracy of thyroid scan were 80%, 20%,  
10%, 90% and 26%, respectively whereas those of FNAC were 80%, 97.7%,  
80%, 97.7% and 96%, respectively. The authors concluded that Fine needle  
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aspiration was a significantly better predictor of malignancy than thyroid scan  
and resulted in a smaller proportion of excisions for benign nodules.(20)  
Sengupta A et al conducted a prospective study to compare the 
advantage of pre-operative FNAC of thyroid swellings with post operative 
histopathology to reach a consensus protocol for optimal management of 
thyroid swellings. The authors studied 178 incidental cases and reported the 
preponderance of colloid goitre (75.84%) followed by granulomatous 
thyroiditis. Follicular carcinoma was noted in 7.30% and anaplastic 
carcinoma in 3.37% cases. Histopathological examination showed 
predominantly colloid goitre (76.97%), followed by follicular carcinoma 
(8.99%). The overall prevalence of malignancy was 11.24% diagnosed by 
HPE, and 9.55% by FNAC. In the FNAC series sensitivity was 90% while 
specificity was 100%; accuracy was 98.88%. Predictive value of a positive 
test and negative tests was 100% and 98.75% respectively. The authors 
concluded that FNAC should be treated as a first-line diagnostic test for 
thyroid swellings to guide the management though this is not a substitute for 
HPE as a need to improve  
primary healthcare in India. (21)  
Sukant Garg et al conducted a retrospective study to evaluate the 
results of FNAC in the diagnosis and management of thyroid lesions. The 
authors reviewed FNAC‟s performed on 434 patients over a period of three 
  
44  
  
years. The cytological results were correlated with clinical features, 
biochemical investigations, and subsequent histopathological examination 
and management of the patients. The most frequently encountered lesion 
was the colloid goitre in 250 (57.60%) cases followed by thyroiditis in 119 
(27.41%) cases, ten (2.30%) adenomatous goitres and two (0.004%) 
thyroglossal cysts.  
14 (1.38%) cases were reported as follicular/Hurthle cell neoplasms and 17  
(3.91%) as malignant tumours. When compared with the clinical diagnosis, 
FNAC proved to be an improvement on the diagnosis of thyroiditis and 
malignancy when compared with that of goitre. FNA revealed a sensitivity 
of 97%, a specificity of 100%, a positive predictive value of 96% and a 
negative predictive value of 100%. They concluded that FNAC is a 
minimally invasive, highly accurate and cost-effective procedure for the 
assessment of thyroid lesions. It also helped in differentiating lesions that 
require surgery from those  
that can be managed otherwise.(22)  
Breast:  
Breast cancer is the second most common cancer among Indian 
females. The cumulative incidence in females until 64 years of age is 1-2%. 
Following public education programs including self-examination and triple 
test, the incidence of early detection of breast lump has increased.   
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Sir James Paget is credited for aspirating malignant cells from a 
breast cancer patient in 1853. Much of the early experience of aspiration 
biopsy was not with “fine” needles but with larger bore cutting needles. The 
popularity of this simple procedure has largely been because of its cost 
effectiveness as well as the inherent qualities of the procedure itself such as 
low complication rate, rapidity, and high diagnostic accuracy. Palpable 
lesions can be effectively biopsied using a thin needle (23 gauge or smaller) 
without radiologic guidance. However, with the current trend of detecting 
smaller, non-palpable lesions, radiologic guidance (mostly ultrasound) is 
needed to adequately sample smaller lesions. The “triple diagnostic 
approach,” which consists of palpation, radiologic findings, and 
cytopathologic analysis on fine needle aspiration (FNA), is applicable to 
benign, pre neoplastic, borderline, and malignant diseases of the breast.   
Ahmed HG et conducted a descriptive longitudinal study at the 
University of Khartoum, Khartoum, Sudan in which they did FNA for 200 
patients with palpable breast lesions and compared findings with tissue 
biopsies taken later. Data were analyzed using a computer's SPSS program.  
Pearson chi-square test was used for statistical analyses. The diagnoses of 
the 200 breast FNAs were as follows: 61 (30.5%) were malignant, 5 (2.5%) 
were suspicious, and 134 (67%) were benign lesions. Subsequent 
histopathological examination was performed on 61 (100%) patients with 
malignant lesions, 5 (100%) of suspicious, and 65 (48.5%) patients of 134 
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patients with benign lesions. FNAC revealed a 92.6% sensitivity, a 95.2% 
specificity, a 95.5% positive predictive value, and a 92.2% negative 
predictive value. They concluded that FNAC of breast lesions was sensitive, 
specific, and highly accurate as the initial investigation of palpable breast 
lesions in a population of low resources and without screening program to 
diagnose breast cancer. (11)  
Pandey A. et al conducted a prospective study at the department of Pathology, 
L.N. medical college, Bhopal, India from January 2016 to December 2016.  
FNAC of 300 cases of palpable breast lesions was done and reported by expert 
pathologist. The histopathological specimen when available was reported by 
another pathologist without prior knowledge. Sensitivity, specificity and 
accuracy of FNA diagnosis was then analyzed. A total of 300 cases of breast 
lesion were diagnosed on FNA, out of them histopathological correlation was 
available for 150 cases. Benign breast lesions were more common in younger 
patients in 11-30 age group and malignant breast lesion were more common in 
the 41-60 years age group. Benign breast lesions were found in 215 cases 
(71.66%); among which fibroadenoma (41%) was the commonest lesion 
observed. Malignancy was observed in 63 cases (21%); among them, Ductal 
carcinoma was the predominant lesion (17.66%). The sensitivity, specificity and 
diagnostic accuracy of FNAC for malignant lesion was found to be 98.3%, 
98.9% and 98.7% respectively. They concluded that FNAC is an effective and 
valid tool as first line diagnostic modality in preoperative diagnosis of malignant 
and benign breast lesions  
Ashish Kosthi et al conducted a retrospective hospital based study at 
the department of Pathology, Gandhi Medical College, Bhopal over a period 
of two and a half years. It included 531 patients with breast lump. FNAC was 
done, 31 (5.84%) cases were not satisfactory and remaining 500 (94.16%) 
were satisfactory for cytological diagnosis. Out of 500 cases, benign lesions 
were 358 (71.60%), malignant lesions were 87 (17.40%), inflammatory 
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lesions were 41 (8.20%) and suspicious category include 14 (2.80%).  
Fibroadenoma was the most common benign lesion and ductal carcinoma 
was the common malignant lesion. The sensitivity, specificity, positive 
predictive value, negative predictive value and accuracy of FNAC was 
98.13%, 100%, 100%, 98.98% and 99.34% respectively. They concluded 
that FNAC of the breast lump is a simple, safe, economical, and rapid 
diagnostic procedure which can be used routinely on OPD basis, because the 
cytopathological examination of these lesions before operation or treatment 
serves as an  
important diagnostic modality.(12)  
Katherine T. Morris et al conducted a diagnostic test study at the 
university hospital multidisciplinary breast clinic. They studied 479 women 
with palpable breast lesions and evaluated them by triple test score (TTS). 
All lesions with TTS less than or equal to 4 were benign on clinical follow 
up. Lesions with TTS greater than or equal to 6 (n=130) were confirmed to 
be malignant on biopsy. Confirmatory biopsy was required only for the 8 % 
of masses that received a TTS of 5. They concluded that TTS reliably guides 
evaluation and treatment of palpable breast masses. (15)  
Problems with FNAC:   
The performance and interpretation of breast FNA require adequate 
training and experience. Correlation with subsequent biopsies and clinical 
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follow-up is mandatory in order to improve the diagnostic yield and 
accuracy of the procedure. Over the years FNA as a means to investigate 
palpable breast lesions became popular, so did the concern over false 
positive and false negative diagnoses among cytopathologists as well in the 
setting of malpractice lawsuits.  
Scott Boerner et al conducted a retrospective study at The University 
of Texas M.D. Anderson Cancer Center to better understand the significance 
of epithelial cellularity, false-negative FNA samples from palpable breast 
lesions.  They reviewed 4455 aspirates of palpable breast masses for 
specimen adequacy in the form of epithelial cell clusters. Aspirates were  
classified as being adequate if a total of six  or more epithelial cell 
clusters(ECC) each comprising ofat least five to ten well preserved cells 
were present on all slides or as inadequate if fewer than six ECC‟s were 
present. From the 4455 aspirates of palpable breast masses, 51 false-negative 
aspirates were identified, 41 of which were available for review. No 
interpretative errors were identified. Twenty-one FNAs (51.2%) were 
classified as adequate and 20 FNAs (48.8%) as inadequate. The adequate 
false-negative aspirates contained between 8 to 100 ECCs. A comparison of 
adequate and inadequate false-negative specimens showed no significant 
differences in the mean age of patients (56.4 years vs. 57.8 years), the mean 
number of FNA passes (3.7 passes vs. 3.0 passes), the mean palpation size 
of the lesions (2.8 cm vs. 2.9 cm), or the mean pathologic size of the lesions 
(2.1 cm vs. 2.2 cm). Cases of invasive lobular carcinoma were more 
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common in the false-negative smears with fewer than six ECCs. They 
concluded that including the number of ECCs as a parameter of adequacy 
could reduce the rate of false-negative FNA diagnoses of palpable breast 
masses by approximately 50%. However, the presence or even abundance 
of ECCs does not eliminate the potential for a false-negative cytologic 
diagnosis. Cytologic diagnoses must be correlated with clinical and imaging 
findings (the triple test) to reduce the rate of falsenegative cases, but benign 
triple test results do not entirely exclude the possibility of carcinoma, and 
such cases require periodic follow-up. (18)  
Lee KR et at conducted a 3 year comparative study at the Medical 
Centre Hospital of Vermont where they analysed all the 503 FNA of breast 
that was performed. There were 93 aspirates diagnosed as "positive," all of 
which were from patients eventually shown to have cancer. However, there 
were 38 patients with primary carcinoma in which the FNA was not 
diagnosed as positive, for a diagnostic failure rate of 31.4%. In order to 
determine the possible effect of technique as practiced by an experienced 
aspirator in diminishing such diagnostic failures, they compared 190 
aspirates obtained by a single individual with 193 aspirates obtained by 15 
individuals in the same community. For the single experienced aspirator, the 
technical failure rate was 9.8% whereas in the group with many aspirators it 
was 45.9%. They  
  
50  
  
concluded that although fine needle aspiration of the breast is considered easy 
to perform, skill on the part of the aspirator is important for satisfactory  
results.(14)  
Scopa, C. D et at conducted study at the Departments of Pathology 
and Surgery, University of Patras Medical School, Patras, Greece. They 
studied 39 cases in which FNA posed diagnostic problems. They concluded 
that these problems could be attributed to sampling errors (71.8%), to the 
criteria of adequacy we use at our institution (2.5.6%), and to interpretation 
(2.6%). The nature of the breast lesion (68%) was the most common cause 
of inadequate  
sampling, followed by the experience of the aspirator (32%).(13)  
Layfield, L. J. et al studied a subgroup of 183 cases with known 
outcome, drawn from a series of 1779 cases, to determine the minimum 
number of cell clusters necessary to ensure that adequate cellular material 
was present for accurate diagnosis. The series included 21 cases 
cytologically diagnosed as false-negative, 75 cases that had been correctly 
identified as benign, 47 cases cytologically designated as atypical, and 40 
cases that on initial review had been correctly identified as malignant. In a 
semi blind fashion, the smears from each case were assigned to low, 
medium, and high cellularity categories. Low cellularity was defined as 10 
or fewer cell clusters, moderate cellularity was defined as 11-30 clusters, 
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and high cellularity was defined as more than 30 clusters. A cell cluster was 
defined as five or more cells. Within the low cellularity group, exact 
numbers of cell clusters and the presence of individual cells were recorded. 
The presence of bipolar cells was used as an adjunct criterion for specimen 
adequacy, and the bipolar cells in each of 10 × 200 fields were counted. 
Cellularity was then correlated with diagnostic accuracy. Using a cutpoint 
of a cumulative score of 6 or more cell clusters or the prominence of bipolar 
cells (≥10 in each of 10 medium-power, ×200 fields) for assessment of 
specimen adequacy, a false-negative rate of 1.5%, associated with an 
unsatisfactory rate of 20.2%, was obtained. The authors concluded that hat 
the sampling false-negative and unsatisfactory rates can be minimized by 
selecting a cut point for satisfactory smears at a level of 6 or more cell 
clusters (cumulative total) or the presence ≥ 10 intact bipolar cells per 10 
medium-power fields (×200). Use of these criteria will decrease the false-
negative rate of sampling in epithelial lesions of the breast. A falsenegative 
rate of approximately 1.5% was obtained in association with an 
unsatisfactory rate of 20.2%. Using a cut point of 1 or more cell clusters, a 
false-negative rate of 2.1%, associated with an unsatisfactory rate of 13.7%, 
was obtained.(19)  
Overall, breast FNA is enormously successful, with an overall 
diagnostic sensitivity ranging from 80% to 100%, with specificity over 99%. 
In the modern era, breast FNA has been confronted with new roles and 
challenges. It is now routinely expected that breast FNA will provide an 
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accurate diagnosis, analyse the biologic behaviour of the tumour, supply 
biomarker information such as oestrogen/progesterone receptor status, 
comment on cell proliferation index, and determine prognostic indicators 
such as Her2neu expression. These expectations can only be met if an 
adequate sample is obtained and the pathologist is on site to triage the 
material for processing.  
Several studies have described the use of stereotactic mammography 
devices for sampling non palpable breast lesions. (72,73)  
High-resolution ultrasound is becoming more common as a 
diagnostic technique in breast and other organs. It is also a very valuable 
tool that can be utilized to guide the needle tip into the target. It allows 
visualization of the needle tip, in real time, as it moves through the target 
and secures the sample.  
This approach provides additional evidence that the sample is truly from the 
correct target area. Ultrasound guidance is particularly suited for non-
palpable breast masses that are visible on ultrasound.   
Although most cytopathologists and clinicians who use fine-needle 
aspiration (FNA) biopsy in their practices are aware of the relationship 
between expertise in microscopic interpretation and diagnostic accuracy, the 
importance of sample quality and smear preparation is less well recognized. 
Several studies have shown that training and experience in obtaining and 
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preparing the samples play a major role in the efficacy of the method. (15,75,76) 
It is much easier to interpret FNA samples microscopically if they are 
abundant, representative, and well prepared. Optimal samples will 
contribute greatly to a very high degree of diagnostic accuracy. Thus, 
operators who are well trained in the sampling technique of various body 
sites will serve patients  
better. (77)  
Sampling issues encountered FNAC:  
1. Cells not collected on sampling devices.  
2. Cells collected but not transferred to slide.  
Interpretive issues:  
1. Abnormal cells present on slide but either not seen or misinterpreted due to 
blood / mucus / air drying artefact..(9)  
  
  
Liquid based cytology:  
Literally means „the study of cells through a liquid medium‟.  
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For many years, efforts have been made to develop methods that 
would enhance the sensitivity and specificity of the Papanicolaou smear. 
Emphasis has been placed on creating automated screening machines whose 
success depends on a representative sampling of cells on standardized slides 
containing a monolayer of well-stained, well-preserved cells.  
From this research and development, liquid-based gynecologic 
specimen collection has evolved. Its proponents argue that liquid-based 
preparations outperform conventional smears because of improved fixation, 
decreased obscuring factors, and standardization of cell transfer. In direct 
smears, the cells are not transferred in a representative fashion and that up 
to 90% of the material scraped from the cervix may be discarded with the 
sampling device. With liquid-based collection, the sampling will be 
representative and operator-dependent variation will not occur since 
processing is controlled by the laboratory.  
SurePath (TriPath Imaging, Inc, Burlington, NC) and ThinPrep 2000 
System (Cytyc Corp, Marlborough, MA) are two such systems approved by 
the FDA for cervicovaginal testing in 1996. With both methods, the sample 
is collected in the conventional manner with one of the brush instruments 
but, instead of being spread onto a glass slide, it is transferred to a vial of 
fixative.  
In the SurePath method, the sample is vortexed, strained, layered onto a 
density gradient, and centrifuged. Instruments required are a 
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computercontrolled robotic pipette and a centrifuge. The cells form a circle 
12.5 mm in diameter.   
The ThinPrep method requires an instrument and special 
polycarbonate filters. After the instrument immerses the filter into the vial, 
the filter is rotated to homogenize the sample. Cells are collected on the 
surface of the filter when a vacuum is applied. The filter is then pressed 
against a slide to transfer the cells into a 20 mm diameter circle.  
Both methods result in a well preserved approximate monolayer of cells, 
with a background devoid of blood and mucus.  
The use of automatic monolayer devices for the preparation of 
nongynecologic material is becoming popular. AutoCyte Prep, now called 
SurePath (TriPath, Inc), and the ThinPrep Processor (Cytyc Corp) have both 
been approved for preparation of nongynecologic material by FDA.  
ADVANTAGES OF LBP:  
1. Almost 100% of the collected cells are captured, processed, and 
reviewed.  
2. Immediate liquid fixation prevents artifacts, such as air-drying.  
3. Easier to review slides, Smaller screening area (TP, 20-mm and SP, 
13mm).  
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4. Preparatory technique reduces debris, cell clumps and obscuring 
elements, cleaner background.  
5. Significantly fewer unsatisfactory cases.  
6. Homogenized specimen - Increased detection of high-grade squamous 
intra-epithelial lesions and above.  
7. Ancillary testing such as reflex human papillomavirus (HPV) test and 
other molecular tests (Chlamydia/gonorrhea), immunocytochemistry can 
be performed from the residual material.  
8. Potential for processing residual material as a cell block.  
  
Michael et al (2001) noted that SurePath offers a somewhat better 
preservation of architecture of cell clusters and cellular integrity than 
ThinPrep.   
Kurtyn and Hoerl cautioned against the indiscriminate use of thin 
layer technology. Serious reservations about the use of this technique were 
also expressed by Michael and Hunter (2000) who also pointed out that the 
ThinPrep technique leads to artifacts and diagnostic pitfalls. (7)  
Salhadar et al concluded that routine use of the ThinPrep technique for 
aspiration biopsy is diagnostically not justified. (78)  
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Papillo et al conducted a study whereby cell yields on cytologic 
preparations made in the Cytospin II cytocentrifuge and the ThinPrep 
Processor was compared. Slides were prepared by each method using 
calibrated volumes (25 microliters) of cell suspensions from 13 non 
gynecologic specimens. Cell counts for each slide were calculated by 
counting cells in predetermined fields using a gridded reticle at 40 x 
magnification, then extrapolated to the total surface area of the preparation. 
The cell counts demonstrated that when processing equal amounts of cell 
suspension, the ThinPrep method retained three times as many cells as the 
cytocentrifuge method. The ThinPrep method, with a higher rate of cell 
recovery, may provide a valuable tool toward more accurate cytological 
diagnosis, particularly for cytology samples with small numbers of cells.(35)  
Martin H. Luu et at conducted a study in which they compared 
preoperative definitive diagnosis of PTC in FNA prepared using 
Thinprep(TP) and conventional smears and FNA prepared with Thin Prep 
alone. Cytological diagnosis of positive for malignancy was correct in 
98.8% of TP + CP cases and in 100% of TP cases. Papillary thyroid 
carcinoma cases were definitively diagnosed in 53.1% of T-FNAs prepared 
by TP + CP compared with 34.4% of T-FNAs prepared with TP alone. They 
concluded that ThinPrep as a sole preparatory technique does not improve 
the usefulness of thyroid FNA as a screening test. However, combining 
Conventional preparation and Thinprep increases the rate of definitive 
cytologic diagnosis of malignancy in papillary  
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thyroid carcinoma.(75)  
Pranab Dey et al conducted a study to compare the various 
cytological features on ThinPrep 2000 and conventional preparation 
specimens from FNAC material by a semiquantitative system. They studied 
71 consecutive cases, first pass was used for conventional smear preparation, 
second mass for TP preparation. TP preparations contained adequate 
diagnostic cells in all cases and were tangibly superior to CP preparations. 
The authors concluded that it was easier and less time consuming to screen 
and interpret TP preparations because cells are limited to smaller areas on 
clean background,  
with excellent nuclear and cytoplasmic morphology.(36)  
Over all technical quality was reported to be improved by ThinPrep 
processing when compared with direct smears on split FNA specimens due 
to cleaner background and better monolayer formation.(36,37)   
Disadvantages of Automated LBP:  
1. Initial high cost for setup.  
2. Retraining of technician and cytopathologist.  
3. Some cytologic details are different in LBC compared with direct 
smears.  
  
59  
  
Some authors, however, advised caution to avoid diagnostic errors 
when interpreting ThinPrep slides due to the increased incidence of the 
following cytologic artifacts : disruption of tissue fragments, formation of 
cell clusters, aggregation of lymphocytes, cellular shrinkage, attenuation of 
nuclear details, and exaggeration of nucleolar prominence.(37,38) In 
comparison with SurePath processed specimens, ThinPrep slides 
demonstrated increased cellular shrinkage, flattening, and fragmentation of 
large cellular sheets and  
nuclear chromatin patterns were reportedly more difficult to evaluate.(38) 
SurePath slides were also found to contain larger branched 3- 
dimensional tissue fragments.(38)  
Claire W. Michael et al conducted a comparative study to assess the 
diagnostic accuracy and different cytomorphological alterations produced 
by ThinPrep and TriPath PREP liquid-based preparations in non-
gynaecologic specimens. They studied 10 urine samples, 4 serous fluids, and 
7 fine-needle aspirates (FNAs) prepared by both techniques. FNAs 
represented one each of: Hashimoto's thyroiditis (HT), hyperplastic colloid 
nodule (HCN), Hodgkin's lymphoma, liposarcoma, chondrosarcoma, 
squamous-cell carcinoma (SCC) metastatic to the lymph node, and carcinoid 
tumor. All 5 participants, none of whom had prior knowledge of the clinical 
history or histologic diagnosis, reviewed and interpreted the slides.  
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Both techniques produced a clean background and were equally 
accurate in urine sample, serous fluids, and three FNAs. TriPath was slightly 
more accurate in four FNAs: HCN and HT wherein colloid and lymphocytes 
were better represented, SCC wherein keratin and malignant cells were more 
readily identified among lymphocytes, and carcinoid which were easier to 
evaluate on TriPath due to the less cellular shrinkage and more dispersion 
of cells between aggregates. ThinPrep preparations had more cell shrinkage, 
and the chromatin was harder to evaluate. Both techniques produced 
artificial aggregations of lymphocytes, but TriPath had a more evenly 
dispersed singlecell population between the aggregates, hence rendering 
them easier to evaluate for atypia. ThinPrep produced fragmentation of large 
sheets that were flattened, while TriPath contained larger branching sheets 
in a threedimensional (3-D) configuration. ThinPrep produced a true 
monolayer of cells that were all spread at the same plane, while in TriPath 
the cells were spread at slightly different planes, requiring frequent focusing 
of the viewed plane.(38)  
While both techniques are acceptable for diagnostic purposes, they both 
introduced new cytomorphologic alterations that pathologists need to 
recognize. TriPath seems superior to ThinPrep in FNAs specimens where 
preservation of architecture and cellular integrity are important.(38)  
Kalpalata Tripathy et al conducted a prospective study on 110 cases 
to assess the diagnostic accuracy of liquid–based cytology versus 
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conventional smears in fine needle aspiration samples. They studied 30 
cases of breast, 40 of lymph node, 10 of salivary glands, 18 of thyroid and 
12 of bone and soft tissue. In each case, two passes were performed. The 
first pass was for conventional preparation (CP) and the second pass yielded 
material for thinprep (TP) preparation. Both CP and TP smears were 
compared for cellularity, background blood and necrotic cell debris, cell 
architecture, informative background, presence of a monolayer of cells and 
nuclear and cytoplasmic details by a semiquantitative scoring system. 
Diagnostic accuracy was better in LBC smears compared with CP smears 
due to lack of background debris and better cell morphology, which was 
performed according to Wilcoxon's signed rank test, yielding a P-value of 
<0.001. However, in some cases, because of a decrease in cell size, 
clustering and altered background in LBC, a support of CP was essential. 
The authors concluded that LBC performed on FNA samples can be a simple 
and valuable technique. Only in few selected cases, where background factor 
is an essential diagnostic clue, a combination of both CP and TP is 
necessary.(8)  
CYTOLOGY OF LBC-PROCESSED THYROID LESIONS:  
BENIGN LESIONS:  
The morphologic picture of LBC differs from CS in two aspects:   
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(a) The cells on the slide are a mono layered representative sample of the 
entire material collected in the vial with a variable amount of cells 
which remains in the preservative solution.  
(b) The automated process causes some changes in both cellular and 
background morphology. One of the most important change, 
occurring in LBC slides, is the appearance of the fragmented colloid 
which is present as small droplets in the background of a benign 
nodule with a quantitative detection whereas in CS the colloid usually 
does not  
require a quantization.(7,70)  
The LBC picture of a thyroiditis is similar to CS with the exception 
of the amount of lymphocytes in the background which can be higher than 
normal because of the spinning of the material before the automated process. 
When a thyroiditis is suspected, the detection of lympho-epithelial clusters 
in an inflammatory background is the pivotal clue for the diagnosis and 
warrants a simple follow-up for the patient.(46)  
Charles V. Biscotti et al analysed 41 samples of ThinPrep and 
Conventional preparations of thyroid FNAC for diagnostic accuracy, 
cellularity pattern of colloid, nuclear and cytoplasmic detail. Of these were 
25 colloid nodules, 6 papillary carcinomas, 4 follicular adenomas, 2 
minimally invasive (encapsulated) follicular carcinomas, 3 Hashimoto's 
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thyroiditis, and 1 Grave's disease. Both techniques identified seven of the 
eight carcinomas with the minimally invasive follicular carcinomas 
categorized as hyper cellular follicular nodule, possibly malignant (HCFN). 
One papillary carcinoma wasclassified as a HCFN by both TP and CS 
techniques. The four follicular adenomas were classified as HCFN based on 
the TP slides. One oxyphilic follicular adenoma, associated with focal 
lymphocytic thyroiditis, was misinterpreted as Hashimoto's thyroiditis on a 
conventional smear. Three colloid nodules were interpreted as HCFN based 
on the TP slides. Two of these were similarly classified based on the 
conventional smear. ThinPrep slides contained less colloid and the colloid 
occurred as droplets rather than a diffuse pattern. TP slides had better nuclear 
detail but more often disrupted cytoplasm. The authors concluded that the 
TP process does alter some cellular features; however, similar diagnostic 
accuracy was experienced with the TP and conventional smear 
preparations.(40)  
FOLLICULAR-PATTERNED LESIONS:  
Diagnosis of follicular neoplasms (FN) in LBC versus CS is based 
upon the identification of micro follicles made up of medium-sized 
thyrocytes in scant colloid.   
(1) Lesions with high cellularity but monomorphic cells and occasional 
enlarged nuclei.   
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(2) Lesion which is mostly follicular-structured and made up of 
mediumsized thyrocytes with rounded nuclei and central nucleolus 
(Follicular Neoplasm) with a malignancy risk between 20 and 30%. 
The action, although debated in the literature, results in the surgical 
removal of the lesion which could histologically correspond to both 
a follicular adenoma or an adenomatous nodule in a goiter (70–80% 
of cases) but also follicular carcinoma or a follicular variant of a 
papillary carcinoma (PC) cannot be ruled out only on morphology. 
The same diagnostic criteria and therapeutic action is applied to the 
FN composed mostly by oxyphilic (or Hurthle) cells which is defined 
when follicles are made up of more than 80% of oxyphilic cells and 
it should be included in the FN category. The colloid amount may be 
scant (but sometimes is abundant) and features of old haemorrhage 
(hemosiderin-laden histiocytes) may coexist   
(3) Follicular-structured lesions, composed of thyrocytes with elongated 
and clear nuclei, sometimes with grooves and peripheral nucleoli 
without papillae, psammomatous bodies, or nuclear pseudoinclusions 
with a risk of malignancy ranging between 50 and 70%. This category 
warrants the surgical removal of the nodule as a follicular variant of 
a PC is very likely to be found at the histological examination (more 
than  
90% of cases).   
MALIGNANT TUMORS:  
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The cytological diagnosis of thyroid malignancy does not differ 
substantially in LBC preparations as the clear background facilitates the 
identification and characterization of the cellular details. The most important 
malignant tumor which can be appropriately identified on LBC preparations 
is PC which is easily when nuclear pseudoinclusions are detected. Papillary 
structures and psammoma bodies are seldom identified. In the earlier reports, 
the difficulty in detecting the distinctive nuclear features of PC was one of 
the most important objections against the adoption of the thyroid LBC 
cytology. Medullary thyroid carcinoma (MTC) is a difficult cytological 
diagnosis.(41)  
The LBC technique offers the opportunity to detect the calcitonin 
expression in the neoplastic parafollicular cells and their concomitant 
negativity for thyroglobulin. Anaplastic thyroid carcinoma (ATC) is seldom 
seen in routine thyroid cytology. TLBC picture of ATC usually shows a 
background of necrotic debris with small clusters of large round or spindle 
cells with pleomorphic nuclei and prominent nucleoli which stains positive 
for cytokeratins (useful to confirm the epithelial origin) and negative for 
thyroglobulin and TTF-1. The LBC diagnosis of the large cell variant of 
malignant non-Hodgkin lymphoma usually does not constitute a problem 
and relies on the immunocytochemical expression of LCA, CD20, bcl-6, and 
other lymphoid antigens. Lung, breast, kidney, large bowel, and laryngeal 
metastatic carcinomas to the thyroid gland may occasionally present as a 
single nodule mimicking a primary tumour in which necrotic debris or 
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hemorrhagic material and clusters of neoplastic cells with features of 
adenocarcinoma or squamous cell carcinoma are detected on Cs and 
ThinPrep2000™.  
Liquid-based preparations (LBPs) have been particularly studied in 
thyroid cytology. The reason for such an interest is related to the critical 
importance of fine-needle cytology in the discrimination between nodule‟s 
candidate to surgery from lesions which might be treated clinically. In this 
setting LBC plays an important role in both achieving a diagnosis and 
providing material for additional techniques (immunocytochemistry, ICC; 
molecular analysis, MA; flow cytometry, FC). (37) Several studies have 
demonstrated the reliability of LBPs applied to thyroid nodules: from the 
classic studies(37,38,40,42,45) to the more recent papers from Europe and the 
USA.(43,44)  
 
 
 
 
 
 
 
  
67  
  
Artefacts more commonly seen with Non gynaecological LBPs:  
Cellularity   Nuclear   Background   
Cellular shrinkage   Increased naked nuclei   Loss of adipose tissue, 
stroma, mucin and colloid.  
Disruption of tissue 
fragments  
Decreased nuclear  
chromatin  details  
Colloid that appears as dense 
droplets.  
Flattening and 
fragmentations of 
large cellular sheets  
Attenuation of nuclear 
grooves and pseudo 
inclusions  
Aggregation  of 
lymphocytes.   
Formation of cell 
clusters  
Exaggerated nucleolar  
prominence  
  
Artificially increased 
single epithelial cells  
    
  
Manual Liquid Based Cytology:  
Arul .P conducted a cross-sectional study, wherein 100 FNA samples  
from various anatomical sites were evaluated using MLBC and CS  
preparations. Cellularity, blood, informative background, monolayers, cell 
architecture, cytoplasmic, and nuclear preservation were compared with 
MLBC and CS preparations by Wilcoxon signed rank test. MLBC  
preparations were identified to be superior to CS preparations in view of 
absence of blood and debris (P = 0.001), presence of monolayers (P < 0.001), 
and preservation of cytoplasmic (P = 0.001) and nuclear details (P = 0.001). 
However, no statistically significant differences were found between MLBC 
and CS preparations with regard to cellularity (P = 0.157), informative 
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background (P = 0.083), and architecture (P = 0.739). The author concluded 
that MLBC preparations in FNAC are a safe, easy, and less time-consuming 
procedure, and it may have promising diagnostic value in the evaluation of 
FNA samples from various anatomical sites. However, the use of both 
MLBC and CS preparations is recommended to achieve optimal diagnostic 
yield.(47)  
Prathima S. et al conducted a prospective study to assess the 
diagnostic efficacy of Manual LBC in FNAC samples. A total of 60 FNA 
samples from various anatomical sites were evaluated. Smears were made 
from conventional preparation (CP) and manual LBC (MLBC) preparation. 
Both CP and MLBC preparations were compared for cellularity, 
background, monolayers, cell architecture, cytoplasmic and nuclear details 
by a semiquantitative scoring system. The diagnostic accuracy was better in 
MLBC compared to CP in view of absence of blood and debris, presence of 
monolayers and preservation of nuclear and cytoplasmic details. However, 
with regard to cellularity, informative background and cell architecture there 
was no statistical significance. The authors concluded that MLBC performed 
on FNA samples can be safe, cost effective promising diagnostic technique 
in combination with CP to achieve high diagnostic yield. (48)  
Pawar .P.S. et al compared 50 cases examined by CS and MLBC 
prepared from cells trapped in needle hub. Direct smears and MLBC smears 
were compared for cellularity, background, cellular preservation, and 
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nuclear preservation. Slides were diagnosed independently by two 
cytologists with more than 5 years‟ experience. Standard error of proportion 
was used for statistical analysis. Cellularity was low in MLBC as compared 
with  
conventional smears, which is expected as remnant material in the needle 
hub was used. Nuclei overlap to a lesser extent and haemorrhage and 
necrosis was reduced, so cell morphology can be better studied in the MLBC 
technique. MLBC technique gives results comparable to the conventional 
technique with better morphology. In a set up where aspirators are learners, 
this technique  
will ensure adequacy due to remnant in needle hub getting processed. (52)  
Mahinder K. et al compared CS and MLBC in 100 women with breast 
carcinoma. Sensitivity and specificity for both MLBC and CS was 95.2% 
and 100% respectively. Positive predictive value and negative predictive 
value for MLBC and CS was 100% and 96.9% respectively. Oestrogen 
receptor analysis performed on five unstained MLBC smears as well on 
biopsy sections of the same five cases were reported as negative. The authors 
concluded that Manual Liquid based cytology can be safely used as an 
important adjunct to  
conventional FNA. Liquid based cytology ensures better cellular 
preservation, less cell overlapping and elimination of blood and excessive 
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inflammation compared to CS. Manual liquid cytology is a technique which 
can be as  
effective a diagnostic tool as CS in low-resource settings like India. Utilization 
for ancillary tests such as ICC for hormonal receptors and molecular biology is  
an additional advantage of MLBC. (51)  
Bandoh, N et al compared CS with LBC on 165 patients with cervical 
lymphadenopathy.81 (49.1%) were diagnosed as benign lymph node and 84 
(50.9%) were malignant diseases including 37 (22.4%) of metastatic 
carcinoma except for thyroid carcinoma, 30 (18.2%) of metastatic thyroid 
carcinoma, and 17 (10.3%) of malignant lymphoma. The overall statistical 
values including sensitivity, specificity, positive predictive value, negative 
predictive value, and accuracy of the CS were 75%, 100%, 100%, 78.9%, 
and  
87.1%, respectively, whereas those values for LBC were 91.2%, 100%, 
100%, 90.7%, and 95.3%, respectively. The authors concluded that the 
sensitivity of LBC for malignant diseases tended to be higher than that of 
CS cytology  (49)  
Surabhi et at compared the efficacy of MLBC versus CS in smears taken 
from oral cavity in 21 patients using cytobrush. MLBC technique produced 
a significant number of satisfactory smears with regard to cell distribution, 
clarity/resolution, staining characteristics and background/artefacts 
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compared to conventional methods. The authors concluded that MLBC is a 
cost-effective cytological technique that may produce oral smears with 
excellent  
cytomorphology and longer storage life. (50)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
METHODOLOGY:  
 The present study was conducted in the Department of Pathology, Sree  
Mookambika Institute of Medical Sciences, Kulasekharam, Kanyakumari District,  
Tamilnadu.  In the present study the samples were taken from the Department of  
General Surgery, Sree Mookambika Institute of Medical Sciences, Kulasekharam, 
Kanyakumari District, Tamilnadu.  The specimens in this consisted of pap stained 
smears prepared conventionally and using UPREP LBC kit.  
a) Study design: Comparative Study.   
b) Approximate total duration of the study: One and half years.  
c) Number of Samples to be studied: Two groups.   
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Group one: Specimen for conventional smear.  
Group two: Specimen for UPREP liquid based preparation smear.  
d) Detailed description of the groups:   
All men and women in the age group of 20-60 years attending the 
General Surgery OPD of SMIMS, Kulasekharam, during the period of 
January 2016 to June 2017.  
e) Sample Size of each group:  
 55  
f) Total sample size of the study:  
110  
g) Scientific basis of sample size used in the study:  
n=Z1√ [2P (1-P)] + Z2√P1 (1-P1) +P2 (1-P2)] 2  
 
(P1-P2)2  
Where  
P1 = Probability of outcome in cell prep plus =73% (Yong Moon-
Lee) P2 = Probability of outcome in Thin prep= 50%  
  
Level of Confidence = 95% (7) 
Level of Power of test=80%  
Z1 = Z value associated with set level of alpha = 1.644  
Z2 = Z value associated with set level of beta = 0.841  
Hence Sample size = 54.28 ≈55  
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h) Sampling Technique: convenient sampling   
i) Ethics Committee Approval:  
The study was approved by the Institutional Human Ethics Committee with 
reference    number SMIMS/IHEC/2015/A/11   
j) Inclusion Criteria:   
Patients attending General Surgery OPD of SMIMS with palpable lesions 
in thyroid, breast   and lymph node who were sent for fine needle 
aspiration study.  
k) Exclusion Criteria:    
Those that are not willing to participate.  
Those patients who have undergone chemotherapy / radiotherapy.  
l) Method of collection of data and procedure:  
Patients attending the General Surgery OPD at SMIMS who have been  
advised fine needle aspiration will be selected. After a detailed history, and thorough 
clinical examination, the skin over the area to be sampled is disinfected using alcohol 
swab.  FNA is done using standard disposable syringes fitted with 23G needle. The 
lesion is palpated and fixed between the left index and middle finger (in case of small 
lesions) of the examiner. Needle positioned within the target tissue.  Plunger is pulled 
to apply negative pressure, needle moved back and forth inside target lesion. Negative 
pressure is released while needle remains in target tissue and then the needle is 
withdrawn. Needle then detached and air drawn into syringe. One small drop of sample 
is blown onto a microscopy slide and then the smear is made. Then it is immediately 
placed in alcohol for fixation. This is the first pass and this slide will be stained with 
pap stain (conventional preparation). The procedure is repeated, however instead of 
air, preservative solution is drawn into the syringe. The needle with aspirated material 
is attached to syringe, plunger is pushed down gently to expel the material along with 
preservative into a conical plastic screw capped container. The syringe is washed two 
to three times with the preservative to make sure no material is present in the syringe. 
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The sample is then kept as such for 30 minutes. The preserved sample is then 
centrifuged in a Swinging type centrifuge at 1000 RPM for 10 minutes. Discard the 
supernatant and then agitate the pellet to get a homogenous sample. Add one or two 
drops of preservative solution over the pellet and mix well again. Add a drop of fixative 
solution to the slide and take 50µl of the diluted sample and smear over them. Allow 
the smear to air dry and proceed for staining.  
  
  
  
m) Parameters to be studied:  
 Screening of Smears by Microscopy:     
• Cellularity  
• Background  
• Monolayer  
• Cellular morphologic change (architectural and cytoplasmic distortion, 
cytoplasmic vacuolation, cellular elongation, folded cytoplasmic borders).  
• Nuclear changes (nuclear hyperchromasia, coarse chromatin, prominent  
nucleoli, irregular nuclear borders, atypical mitosis).  
• Inflammatory infiltrate  
n)   Method/Technique/Instrument/Reagent/Kit etc. used along with their 
manufacturing source details:  
• Tissue sampling  
• Light Microscope   
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UPREP LBC kit marketed by Regenix Drugs LTD, #11, First Floor, 
Loganathan Nagar, 3rd Street, Choolaimedu, Near MMMDA Metro Station, 
Chennai- 600094. E mail: www.info@uprepindia.com  
Chemicals used for staining procedures:  
Processing chemicals and materials:  
 Xylene.  
 Alcohol (different grades)  
 DPX  
 Frosted microslide 75mm long, 25mm wide, and 1.25mm thick.  
 Microscopic coverglass 22mmx22mm.  
Procedure for Papanicolaou Staining:  
1. 70 % Isopropyl Alcohol – 1min  
2. 50 % Isopropyl Alcohol – 1min  
3. Distilled water – 1 min  
4. Harris Hematoxylin – 1min and 30 seconds  
5. Tap Water – 1 min  
6. 0.5% HCL in 70 % Isopropyl Alcohol – 1 dip  
7. Distilled water – 5 min  
8. Ammoniated Alcohol Solution – 1 min.  
9. Running tap water – 15 min  
10. 50 % Isopropyl Alcohol – 1min  
11. 70 % Isopropyl Alcohol – 1min  
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12. 80 % Isopropyl Alcohol – 1min  
13. OG6 solution – 1 min  
14. 95 % Isopropyl Alcohol – 1min  
15. 95 % Isopropyl Alcohol – 1min  
16. EA 50 – 1min  
17. 95 % Isopropyl Alcohol – 1min  
18. 95 % Isopropyl Alcohol – 1min  
19. Absolute Isopropyl Alcohol – 3min  
20. Absolute Isopropyl Alcohol – 3min  
21. Xylene – 2 min  
22. Xylene – 2 min  
23. Mount in DPX  
Enumeration:  
The stained smears were seen under ADelta Plan ZTMAP40 with APCAM-5  
Binocular CCD attached microscope.   
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They are then scored according to the semi quantitative scoring system.  
Table 1: Semi quantitative Scoring system used in FNA Smears:   
Cytological features  Score 0  Score 1  Score 2  Score 3  
Cellularity  Zero  Scanty  Adequate  Abundant  
Background blood & 
debris  
Zero  occasional  Good amount    
Informative 
background (Colloid, 
Mucus, and Stromal 
fragments).  
Absent  Present   -----
-  
 -----
-  
Monolayer  Absent  Occasional  Good amount  ------  
Cell architecture  Non 
Recognised  
Moderately 
Recognised  
Well 
Recognised  
------  
Cytoplasmic details  Poor  Fair  Good  Excellent  
Nuclear details  Poor  Fair  Good  Excellent  
  
Statistical Analysis  
Data collected will be entered in Excel data sheet and analysis done on SPSS 
software.  
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Conventional Smear - Fibroadenoma  
   
UPREP LBC –Fibroadenoma  
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Conventional Smear - carcinoma breast  
  
   
UPREP LBC- Carcinoma Breast  
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CS – Colloid Goitre  
  
  
UPREP – Colloid Goitre  
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CS- Hashimotos Thyroiditis  
  
UPREP – Hashimotos Throiditis  
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CS – Reactive lymphadenopathy  
  
   
UPREP - Reactive lymphadenopathy  
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STATISTICS  
SOCIODEMOGRAPHIC CHARACTERISTICS:  
AGE DISTRIBUTION:  
The distribution of age in the study participants in both conventional 
and uprep group ranges from 14 to 67 years. The mean age of study 
participants in both conventional and uprep groups were 42.78 years (95% 
CI is 39.523, 46.037) with a SD of 12.327 years.  
Distribution according to age of participants:  
Age characteristics  Conventional group  Uprep group  
Minimum  
Maximum  
Mean  
Standard deviation  
14  
67  
42.78  
12.327  
14  
67  
42.78  
12.327  
  
 Majority of the study participants were 40-49 years of age group (34.5%), 
followed by 30-39 years of age group (20%) in both conventional and uprep 
groups.  
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Age distribution in the study population  
Age group  Conventional group  Uprep group  
Frequency  Percent  Frequency  Percent  
10-19  2  3.6  2  3.6  
20-29  8  14.5  8  14.5  
30-39  
  40-
49  
11  20.0  11  20.0  
19  34.5  19  34.5  
50-59  9  16.4  9  16.4  
60-69  6  10.9  6  10.9  
Total  55  100  55  100  
  
Age of the study participantsin both conventional and uprep groups  
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SEX  
In this study majority of the study participants were females (96.4%) in both 
conventional and uprep group.  
Distribution of sex in the study population:  
  
Sex  Conventional group  Uprep group  
Frequency  Percent  Frequency  Percent  
Female  53  96.4  53  96.4  
 
 Mal
e  
2  3.6  2  3.6  
Total  55  100  55  100  
  
Gender of the study population in both conventional and uprep groups  
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SITE  
Distribution of site in the study participants  
In this study majority of the cases were thyroid lesions (27 cases) 
followed by breast lesions (25 cases) and lymphadenopathy (3 cases)  
  
Site  Conventional group  Uprep group  
Frequency  Percent  Frequency  Percent  
Breast  
Thyroid  
  
Lymph node  
25  45.5  25  45.5  
27  49.1  27  49.1  
3  5.5  3  5.5  
  
  
  
96.4 %   
3.6 %   
Female  
Male  
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Total  55  100  55  100  
  
 
  
DIAGNOSIS  
In the present study cytological diagnosis of both groups were similar. 
Hence the diagnostic accuracy of UPREP LBC was similar to CS with regard 
to benign and malignant conditions.  
Diagnosis in both conventional and uprep groups  
  
Diagnosis  Conventional group  Uprep group  
Frequency  Percent  Frequency  Percent  
11  20.0  11  20.0  
Site  
  
  
45.5 %   
49.1 %   
5.5 %   
Breast  
Thyroid  
Lymph node  
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Breast fibroadenoma  
Breast carcinoma  
Thyroid benign  
Hashimotos thyroiditis  
 FLUS  
Papillary Thyroid  
14  25.5  14  25.5  
8  14.5  8  14.5  
10  18.2  10  18.2  
6  10.9  6  10.9  
    
Carcinoma  
Reactive Lymph node  
Total  
3  5.5  3  5.5  
3  5.5  3  5.5  
55  100  55  100  
  
Diagnosis in both conventional and uprep groups 
 
CELLULARITY  
Cellularity in the study population  
  
Cellularity is both the groups are almost similar. CS having an 
adequate cellularity of 30.9% when compared to 36.4% in MLBC group. 
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Abundant cellularity was noted in 69.1% in CS group and it was 63.6% in 
MLBC group.   
 
  
 Cellularity   Conventional group  Uprep group  
Frequency  Percent  Frequency  Percent  
Adequate  
  Abundant  
Total  
17  30.9  20  36.4  
38  69.1  35  63.6  
55  100  55  100  
  
  
    
Cellularity in the conventional group  
 
  
  
  
30.9 %   
69.1 %   
Adequate  
Abundant  
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Cellularity in the uprep group  
 
INFORMATIVE BACKGROUND  
Informative background in the study population  
  
  
Informative 
background  
Conventional group  Uprep group  
Frequency  Percent  Frequency  Percent  
Absent  
Present  
  
Total  
2  3.6  40  72.7  
53  96.4  15  27.3  
55  100  55  100  
  
  
Informative background in both conventional and uprep groups  
  
  
    
36.4 %   
63.6 %   
Adequate  
Abundant  
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BACKGROUND DEBRIS  
  
Background debris in both conventional and UPREP groups  
  
Background debris  Conventional group  Uprep group  
Frequency  Percent  Frequency  Percent  
Absent  
Scanty  
  
Abundant  
Total  
30  54.5  53  96.4  
22  40.0  2  3.6  
3  5.5  0  0  
55  100  55  100  
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72.7 %   
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Background debris in the conventional group  
 
    
Background debris in the uprep group  
 
INFLAMMATORY CELLS  
  
  
  
54.5 %   
40 %   
5.5 %   
Absent  
Scanty  
Abundant  
  
  
  
96.4 %   
3.6 %   
Absent  
Scanty  
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Inflammatory cells in the study population  
  
Lymphocytes was the predominant group of inflammatory cells present in the 
smears studied.  
  
Inflammatory  
cells  
Conventional group  Uprep group  
Frequency  Percent  Frequency  Percent  
Absent  
  Present  
Total  
23  41.8  42  76.4  
32  58.2  13  23.6  
55  100  55  100  
  
  
  
  
  
Inflammatory cells in the conventional group  
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Inflammatory cells in the uprep group  
 
  
MONOLAYER  
  
  
  
41.8 %   
58.2 %   
Absent  
Present  
  
  
76.4 %   
23.6 %   
Absent  
Present  
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Monolayer in the study groups   
  
Monolayer   Conventional group  Uprep group  
Frequency  Percent  Frequency  Percent  
Absent   
Occasional  
 
Abundant  
Total  
9  
44  
16.4  
80  
0  
1  
0  
1.8  
2  3.6  54  98.2  
55  100.0  55  100  
  
  
Monolayer in both conventional and uprep groups  
 
CELL ARCHITECTURE  
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Cell architecture in both conventional and uprep groups  
  
Cell architecture  Conventional group  Uprep group  
Frequency  Percent  Frequency  Percent  
Absent  
Occasional  
  
Abundant  
Total  
13  23.6  3  5.5  
38  69.1  40  72.7  
4  7.3  12  21.8  
55  100  55  100  
  
  
Cell architecture in the conventional group  
  
  
  
Cell architecture in the uprep group  
  
  
  
23.6 %   
69.1 %   
7.3 %   
Absent  
Occasional  
Abundant  
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CYTOPLASM  
Cytoplasm in both conventional and uprep groups  
  
  Cytoplasm   Conventional group  Uprep group  
Frequency  Percent  Frequency  Percent  
Not clear  
Clear   
  
Very clear  
Total  
12  21.8  3  5.5  
30  54.5  0  0  
13  23.6  52  94.5  
55  100  55  100  
  
  
  
  
Cytoplasm in the conventional group  
  
  
5.5 %   
72.7 %   
21.8 %   
Absent  
Occasional  
Abundant  
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Cytoplasm in the uprep group  
 
NUCLEUS DETAILS  
Nucleus details in the study population  
  
  
  
21.8 %   
54.5 %   
23.6 %   
Not clear  
Clear  
Very clear  
  
  
Not clear  
Clear  
Very clear  
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Nucleus details  Conventional group  Uprep group  
Frequency  Percent  Frequency  Percent  
Not clear  
Clear  
  
Excellent details  
Total  
13  23.6  3  5.5  
28  50.9  4  7.3  
14  25.5  48  87.3  
55  100  55  100  
  
Nucleus details in both conventional and uprep groups  
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RESULT  
In the present study comparison of cellularity, informative 
background, background debris, inflammatory cells, monolayer, cell 
architecture, cytoplasm and nucleus details of FNAC smears in both 
conventional and uprep group was done using chi-square test. p value less 
than 0.05 was considered as significant i.e, there is a difference in FNAC 
smears made by conventional preparation and UPREP liquid based 
preparation.  
 In this study informative background, background debris, 
inflammatory cells, monolayer, cell architecture, cytoplasm and nucleus 
details of FNAC smears in both conventional and uprep groups were found 
to be significant (p<0.05).   
  
101  
  
COMPARISON OF CELLULARITY  
  
Cellularity  
Gr oup    
Total  Conventional  
N (%)  
Uprep 
N (%)  
Adequate  17 (45.9)  20 (54.1)  37  
Abundant  38  (52.1)  35 (47.9)  73  
Total  55  55  110  
χ2 = 0.367    df = 1     p=0.545  
  
  
  
COMPARISON OF INFORMATIVE BACKGROUND  
  
Informative 
background  
Gr oup    
Total  Conventional  
N (%)  
Uprep 
N (%)  
Absent  2 (4.8)  40 (95.2)  42  
Present  53  (77.9)  15 (22.1)  68  
Total  55  55  110  
χ2 = 55.61    df = 1     p=0.001*  
  
  
COMPARISON OF BACKGROUND DEBRIS  
  
  Group      
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Background  
debris  
Conventional  
N (%)  
 Uprep N 
(%)  
Total  
Absent  30(36.1)   53 (63.9)   83  
Scanty  22  (91.7)   2 (8.3)   24  
Abundant   3 (100)  0   3   
Total  55   55   110   
χ2 = 27.389     df = 2     p=0.001*  
  
  
  
  
  
COMPARISON OF INFLAMMATORY CELLS  
  
Inflammatory  
cells  
Gr oup    
Total  Conventional  
N (%)  
Uprep 
N (%)  
Absent  23 (35.4)  42 (64.6)  65  
Present  32  (71.1)  13 (28.9)  45  
Total  55  55  110  
χ2 = 13.576     df = 1     p=0.001  
  
COMPARISON OF MONOLAYER  
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Monolayer  
Gr oup    
Total  Conventional  
N (%)  
Uprep N 
(%)  
Absent  9 (100)  0  9  
Occasional  44  (97.8)  1 (2.2)  45  
Abundant  2 (3.6)  54 (96.4)  56  
Total  55  55  110  
χ2 = 98.375     df = 2     p=0.001*  
  
  
  
  
  
COMPARISON OF CELL ARCHITECTURE  
  
Cell 
architecture  
Gr oup    
Total  Conventional  
N (%)  
Uprep N 
(%)  
Absent  13 (81.2)  3 (18.8)  16  
Occasional  38  (48.7)  40 (51.3)  78  
Abundant  4 (25)  12 (75)  16  
Total  55  55  110  
χ2 = 10.301     df = 2     p=0.006*  
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COMPARISON OF CYTOPLASMIC DETAILS  
  
Cytoplasm  
Gr oup    
Total  Conventional  
N (%)  
Uprep N 
(%)  
Not clear  12 (80)  0  12  
Clear  30 (100)  5  35  
Very clear  13 (20)  50 (80)  63  
Total  55  55  110  
χ2 = 58.8     df = 2     p=0.001*  
  
  
  
  
COMPARISON OF NUCLEUS DETAILS  
  
Nucleus details  
Group     
Total  Conventional  
N (%)  
 Uprep N 
(%)  
Not clear  13 (81.2)   0  13  
Clear  28 (87.5)   7 (12.5)  35  
Excellent details  14 (22.6)   48 (77.4)  62  
Total  55   55  110  
χ2 = 42.895     df = 2     p=0.001* DISCUSSION:  
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Currently, FNA has a significant role in the evaluation of palpable 
lesions, however the success of FNA depends immensely upon correct 
preparation of cytological smears and skills of the person performing the  
procedure. (53-55)  
Gerhard R et al observed that the number of passes performed and the 
skill of the person performing the procedure determine to a large extent the 
quality and cellularity of the FNA samples. (56)   
Liquid based cytology was approved by FDA in 1996 viz. ThinPrep™  
(TP; Hologic, Marlborough, Mass., USA) and the SurePath™ (SP; BD 
TriPath, Burlington, N.C., USA) for gynaecological samples. They helped 
to overcome problems related to poorly prepared and ill preserved smears. 
Subsequently the use of LBC extended to non-gynaecological samples  
including FNA and effusion fluids. (57)  
Many authors have evaluated both gynaecological and non- 
gynaecological specimens using LBC preparations and have attributed 
benefits over CS namely increased cellularity, lack of obscuring background 
material, improved morphology, and a decrease in the rate of unsatisfactory 
or less than optimal specimens.  
LBC technique is far easier, quicker, and safer and requires less skill.  
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The advantages of using the LBC technique are minimal obscuring factors  
(blood, debris and necrotic materials), excellent cell preservation, lesser fixation 
artefacts (air-drying), monolayered distribution, less overlapping of the cells 
and fewer numbers of slides requiring examination.  
 However, due to chemical influences of the fixation medium and 
physical force of centrifugation, LBC tends to produce certain  
cytomorphological alterations and artefacts. Smaller cell clusters and sheets, 
more dyscohesive cells, breakage of papillae, attenuated chromatin details 
with prominent nucleoli, intra nuclear inclusion is difficult to visualize, 
altered background matrix in both quantity and quality, aggregation of 
lymphocytes and markedly decreased number of extracellular particles, red 
blood cells, and myoepithelial cells.(58) Hence, interpreting pathologists 
should be cautious to avoid misinterpretations while reporting FNA prepared 
using LBC if that is the only methodology employed.(47)  
Garbar et al. did a study on FNAC of lymph node with CS and LBC 
at two university hospitals and concluded that despite the cost, the efficiency 
of lymph node FNAC is identical between CS and LBC. (59)  
The present study was conducted in the Department of Pathology, 
Sree Mookambika Institute of Medical Sciences, Kulasekharam, Tamil Nadu  
and comprised of 55 cases. Out of which, 11 were fibroadenoma of breast 
and 14 were carcinoma breast, 8 were benign thyroid lesions, 10 were 
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hashimotos thyroiditis, 6 were Follicular Lesions of Unknown Significance, 
3 were  
Papillary Carcinoma Thyroid and two reactive lymphadenopathy.  
In each case, conventional smear was prepared from first pass 
material and MLBC smear was prepared from the second pass material. This 
was to ensure that the cellularity would not be compromised upon. The 
diagnosis in both groups were the same hence the diagnostic accuracy of 
UPREP LBC is similar to conventional smear.  
Cellularity  
In the present study the cellularity for UPREP LBC was almost 
equivalent to conventional smear. Dey P. et al in their study utilized a 
separate pass entirely for MLBC, and the cellularity became almost 
equivalent to CS.(36) Perez-Reyes et al employed split sampling technique 
where they divided the aspirate into two halves, one for LBC and the other 
for CS, hence in their study the cellularity of LBC was inferior to CS.(60) 
Gerhard R et al observed that the number of passes performed and the skills 
of the person performing the procedure determine the quality and cellularity 
of the  
samples.(56)  
Informative Background  
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The diagnosis of fibroadenoma breast is classically rendered on the 
basis of visualization of ductal cell aggregates, bipolar cells and stromal 
fragments. In the present study, 11 cases of fibroadenoma were analysed. CS 
met the diagnostic criteria in all cases, however UPREP LBC slides showed 
an absence of fibromyxoid stroma in all except 1 case. This was in 
concordance with other studies. Pervez et al concluded that the diagnosis of 
fibroadenoma seems to be most problematic on LBC preparations.(60) Some 
studies showed a low diagnostic rate compared to CS and false-positive 
diagnoses while over classifying fibroadenomas as atypical or 
suspicious.(40,53,60)  
Based on the presence of monolayer, rich cellularity, detailed nuclear 
features, and clean background, the diagnosis of breast carcinoma was made 
in the present study. Both LBC and CS preparations have comparable 
performance for the detection of breast carcinoma. Dey et al.,concluded that 
the diagnosis of ductal carcinoma was easier on LBC due to clean 
background, lack of necrosis/ haemorrhage and detailed nuclear features of 
tumor cells.(36)  
Amount of colloid in the background plays an important role in the diagnosis 
of benign and follicular lesions of thyroid. In this study, the amount of 
colloid on UPREP LBC  was diminished and appeared fragmented, and in 
droplets.  
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Nuclear grooves and pseudoinclusions were apparent in papillary carcinoma. 
However, Lee et al., observed that background material were slightly 
superior in LBC preparation than CS preparation. (15)  In thyroid lesions, the 
present study found that MLBC preparations should be interpreted with great 
caution and CS should always be employed to confirm the diagnosis. 
Similarly, few  
workers demonstrated these problems in their study.(8,61,62)  
Background Debris  
The amount of obscuring background debris was almost negligible in  
UPREP LBC preparations when compared to CS preparation. This resulted in 
better visualization of cells with greater ease of diagnosis and a reduction in  
the need for repeat FNAC‟s. (44,45,47,50,59,61)  
In the current study, there was statistically significant differences 
between  CS preparations and UPREP LBC  in view of informative 
background, background debris, inflammatory cells, monolayer, cell 
architecture, cytoplasm and nucleus details (p<0.05). However, no 
statistically significant difference was found between these two groups with 
regard to cellularity, (P > 0.05).   
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CONCLUSION:  
Fine needle aspiration is a safe and cost effective method for the 
diagnosis of palpable lesions at various anatomical sites. However, adequate 
preparation of smears determines the quality of FNA. Manual liquid based 
cytology like UPREP LBC is an accurate, less expensive alternative 
procedure to automated LBC with the advantage of providing monolayer, 
absence of obscuring blood or debris, better nuclear and cytoplasmic 
morphology. It is prudent to recognize certain distinct changes in LBC 
smears in order to avoid interpretative errors. Because of that, training before 
screening and interpreting LBC preparations is highly recommended. 
Manual LBC can be used as a adjunct with conventional preparation.  
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SUMMARY  
UPREP liquid based cytology is a novel system of manual liquid 
based cytology. Automated LBC systems have been in use since the late 
1900s. The advantages include improved sensitivity, specificity due to better 
fixation of cells, reduced air drying artefact, obscuring factors like blood, 
monolayer preparation, better cytomorphology of nucleus and cytoplasm. 
This has therefore resulted in a lower rate of unsatisfactory cytology 
samples. There was also added advantage, the residual material could be 
used for making further smears, special stains, immunocytochemistry. 
However, the initial high cost of setup have resulted in the development of 
manual LBC kits.  
This study encompassed 55 cases, in whom FNAC was done. 
Material from the first pass was used to prepare smear in the conventional 
smear method. Material from the second pass was prepared using UPREP 
LBC technique. Both slides were compared for cellularity, informative 
background, background debris, monolayer, cell architecture, nuclear and 
cytoplasmic details using a semi – quantitative scoring system. The results 
were analysed using chi-square test.  
Out of the 55 cases, 11 were fibroadenoma of breast and 14 were 
carcinoma breast, 8 were benign thyroid lesions, 10 were Hashimotos 
Thyroiditis, 6 were Follicular Lesions of Unknown Significance, 3 were 
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Papillary Carcinoma Thyroid and two were found to be reactive 
lymphadenitis. The diagnosis in both groups did not change hence the 
diagnostic accuracy of UPREP LBC is similar to conventional smear. With 
respect to cellularity no significant difference was noted in both groups. 
Concerning informative background, UPREP LBC showed less diagnostic 
background material particularly in benign lesions of breast and thyroid. The 
absence of necrosis and blood aided in better visualization of cytoplasm and 
nuclear details particularly in malignant cases.  
In the current study, statistically significant differences was observed 
in CS preparations and UPREP LBC with regard to informative background, 
background debris, inflammatory cells, monolayer, cell architecture, 
cytoplasm and nucleus details (p<0.05).    
Manual liquid based preparations like UPREP LBC can be used as a 
low cost alternative to other expensive automated LBC systems. Use of both 
conventional smear and Liquid based cytology can improve the diagnostic 
yield in fine needle aspiration cytology.  
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ABBREVATIONS  
HPV  -  Human Papilloma Virus  
FNAC   -  Fine Needle Aspiration Cytology  
FDA   –  Food and Drug Agency  
CP   –  Conventional Preparation  
TP   –  ThinPrep  
LBC   –  Liquid Based Cytology  
MLBC   –  Manual Liquid Based Cytology  
ND/US   -  Non diagnostic or Unsatisfactory  
HT   –  Hashimotos Thyroiditis  
AUS   –  Atypia of Undetermined Significance  
FLUS   –  Follicular Lesion Of Undetermined Significance  
PTC   –  Papillary Thyroid Carcinoma  
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ANNEXURE  
The Bethesda System for Reporting Thyroid Cytology (TBSRTC):  
For a thyroid FNA specimen to be satisfactory for evaluation (and 
benign), at least 6 groups of benign follicular cells are required. Each group 
should be composed of at least 10 cells. The minimum size requirement for the 
groups allows one to determine (by the evenness of the nuclear spacing) 
whether they represent fragments of macro follicles. (25,26) Categories :   
I. Non diagnostic or Unsatisfactory:  
1. Cyst fluid only.  
2. Virtually acellular specimen.  
3. Other (obscuring blood, clotting artefact).  
II. Benign:  
1. Consistent  with  a  benign  follicular  nodule 
 (includes  
adenomatoid nodule, colloid nodule, etc).  
2. Consistent with lymphocytic (Hashimoto) thyroiditis in the proper 
clinical context Consistent with granulomatous (sub- 
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acute) thyroiditis.  
3. Other.  
III. Atypia of Undetermined Significance or Follicular Lesion of  
Undetermined Significance.  
IV. Follicular Neoplasm or Suspicious for a Follicular Neoplasm   
(Specify if Hürthle cell (oncocytic) type). V. 
Suspicious for Malignancy:  
1. Suspicious for papillary carcinoma   
2. Suspicious for medullary carcinoma   
3. Suspicious for metastatic carcinoma   
4. Suspicious for lymphoma   
5. Other  
VI.  Malignant:  
1. Papillary thyroid carcinoma.  
2. Poorly differentiated carcinoma.  
3. Medullary thyroid carcinoma.  
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4. Undifferentiated (anaplastic) carcinoma.  
5. Squamous cell carcinoma.  
6. Carcinoma with mixed features (specify).  
7. Metastatic carcinoma.  
8. Non-Hodgkin lymphoma.  
9. Others.  
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